Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This single-center, open-label study will evaluate the safety and efficacy of subcutaneous
heparin anticoagulation compared to the standard of care systemic intravenous anticoagulation
during veno-venous extracorporeal membrane oxygenation for respiratory failure.